A carregar...
CRISPR/Cas9 gene editing for curing sickle cell disease
Sickle cell disease (SCD) is the most common monogenic blood disorder marked by severe pain, end-organ damage, and early mortality. Treatment options for SCD remain very limited. There are only four FDA approved drugs to reduce acute complications. The only curative therapy for SCD is hematopoietic...
Na minha lista:
| Publicado no: | Transfus Apher Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049447/ https://ncbi.nlm.nih.gov/pubmed/33455878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2021.103060 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|